UBS Group AG - BONE BIOLOGICS CORP ownership

BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070303. A total of 5 filers reported holding BONE BIOLOGICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BONE BIOLOGICS CORP
ValueSharesWeighting
Q1 2023$11,306
+252.8%
43,653
+186.0%
0.00%
Q4 2022$3,205
-70.9%
15,263
+98.9%
0.00%
Q2 2022$11,0007,673
+8927.1%
0.00%
Q1 2022$0850.00%
Other shareholders

There were no reported owners of BONE BIOLOGICS CORP in Q1 2022.

NameSharesValueWeighting ↓
View complete list of BONE BIOLOGICS CORP shareholders